3mNHS trust wins puberty blockers appeal
Children aged under 16 with gender dysphoria should be able to take puberty-blocking drugs, even without their parents’ consent, according to a new ruling by the court of appeal.
Judges overturned an earlier decision which cast doubt on children’s capacity to consent to the treatment or understand the long-term consequences.
The appeal was brought by the Tavistock Trust, which runs the only children’s gender identity clinic in the UK. They welcomed today’s ruling, saying it was a matter for doctors, not judges to decide.